Abstract:To date, several on-treatment-level virological and serological indices that may predict the response to interferon alpha (IFN-alpha) have been reported. However, no effective predictors, such as drug-response genes, that can be detected before administration of anti-hepatitis B virus (HBV) therapy with IFN-a, have been found. In the diverse range of chronic viral infection, genes that affect human immunity play important roles in understanding host and viral co-evolution. Killer-cell immunoglobulin-like receptors (KIRs), which are highly polymorphic at the allele and haplotype levels, participate in the antiviral function of natural killer (NK) cells via fine-tuning inhibition and activation of NK-cell responses that occur when the NK cells interact with human leukocyte antigen (HLA) class I molecules on target cells. For each individual, the pairing of KIR and HLA ligand is genetically determined. To investigate whether a particular KIR and HLA repertoire influences the risk of HBV infection and response to IFN-alpha treatment for chronic hepatitis B (CHB), we genotyped the KIRs and HLA ligands of 119 hepatitis B e antigen (HBeAg)-positive CHB patients. These patients included 43 patients who achieved sustained response (SR) induced by IFN-alpha treatment for 48 weeks, 76 patients who achieved no response (NR), and 96 healthy subjects as controls. SR was defined as HBeAg loss with HBV DNA < 2,000 IU/ml and alanine aminotransferase normalization at 24 weeks posttreatment (week 72). In this study, we showed that activating KIR genes were less prevalent in Han Chinese, especially in Han Chinese with CHB, than in Caucasians. Furthermore, the KIR3DS1 gene, in combination with HLA-B Bw4-80Ile, strongly influenced the therapeutic outcomes for CHB patients who were treated with IFN-alpha. The frequency of the combination of genes encoding KIR3DS1 and HLA-B Bw4-80Ile was higher in patients who had a sustained treatment response than in patients who had NR [35.3 versus 1.3%; odds ratio (OR) = 19.85; P = 0.0008]. Activating KIR3DS1 and HLA-B Bw4-80Ile synergistically predicted SR to IFN-a for HBeAg-positive CHB patients. Genotyping for the KIR3DS1 gene and the HLA-B Bw4-80Ile allele might help physicians choose the optimal candidates for anti-HBV treatment with IFN-alpha.

Evaluation of Susceptibility Locus for Response to Interferon-Α Based Therapy in Chronic Hepatitis B Patients in Chinese

Association of Single Nucleotide Polymorphisms in Interferon Signaling Pathway Genes and Interferon-Stimulated Genes with the Response to Interferon Therapy for Chronic Hepatitis C

A Functional SNP of Interferon-Γ Gene is Important for Interferon-Α-induced and Spontaneous Recovery from Hepatitis C Virus Infection

KIR3DS1/HLA-B Bw4-80Ile Genotype is Correlated with the IFN-α Therapy Response in Hepatitis B E Antigen-Positive Chronic Hepatitis B

Human leukocyte antigen class I and class II genes polymorphisms might be associated with interferon α therapy efficiency of chronic hepatitis B.

Polymorphisms in Adar1 Gene Affect Response to Interferon Alpha Based Therapy for Chronic Hepatitis B in Han Chinese

IFIT1 Polymorphisms Predict Interferon-Α Treatment Efficiency for Hepatitis B Virus Infection.

No Association Between IFNL3 (IL28B) Genotype and Response to Peginterferon Alfa-2A in HBeAg-positive or -Negative Chronic Hepatitis B.

Treated with Interferon and the Gene Polymorphism of CGRP and Its Receptor.

HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients

Association of IL28B Genotypes and Baseline Serum Interferon-γ-Inducible- Protein-10 Levels with Treatment Response in Hepatitis C Virus Patients in China

Polymorphisms in IRG1 gene associated with immune responses to hepatitis B vaccination in a Chinese Han population and function to restrain the HBV life cycle

Genetic Variation in STAT4 Predicts Response to Interferon‐α Therapy for Hepatitis B E Antigen‐positive Chronic Hepatitis B

Association study of IL28B: rs12979860 and rs8099917 polymorphisms with SVR in patients infected with chronic HCV genotype 1 to PEG-INF/RBV therapy using systematic meta-analysis.

Association of Candidate Susceptible Loci with Chronic Infection with Hepatitis B Virus in A Chinese Population

Role of Functional IFNL4, IFNLR1, IFNA, IFNAR2 Polymorphisms in Hepatitis B virus-related liver disease in Han Chinese population.

Genetic Variation in FCER1A Predicts Peginterferon Alfa‐2a‐induced Hepatitis B Surface Antigen Clearance in East Asian Patients with Chronic Hepatitis B

Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B.

Polymorphisms of Interferon-Inducible Genes OAS Associated with Interferon-Α Treatment Response in Chronic HBV Infection

An intronic genetic variant of ZHX2 predicts response to pegylated interferon α therapy in HBeAg-positive chronic hepatitis B patients

Association Between Polymorphisms of the Cytokine and Cytokine Receptor Genes and Immune Response to Hepatitis B Vaccination in a Chinese Han Population.